These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 1095309
1. Clinical trial of a low dose combined oral contraceptive ('Ovranette'). Foss GL, Fotherby K. Curr Med Res Opin; 1975; 3(2):72-6. PubMed ID: 1095309 [Abstract] [Full Text] [Related]
4. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version. Carlborg L. Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925 [Abstract] [Full Text] [Related]
6. Analysis of a multicentre trial of a new low-dose oral contraceptive in Great Britain. Bye PG. Acta Obstet Gynecol Scand Suppl; 1976 May; 54():61-6. PubMed ID: 788447 [Abstract] [Full Text] [Related]
8. Assessment of incremental dosage regimen of combined oestrogen-progestogen oral contraceptive. Brosens IA, Robertson WB, Van Assche FA. Br Med J; 1974 Dec 14; 4(5945):643-5. PubMed ID: 4441832 [Abstract] [Full Text] [Related]
9. [Clinical evaluation of Rigevidon used for contraception]. Marianowski L, Grezechocińska B. Ginekol Pol; 1984 Aug 14; 55(8):631-5. PubMed ID: 6396173 [Abstract] [Full Text] [Related]
12. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles. Landgren BM, Diczfalusy E. Contraception; 1984 May 14; 29(5):437-46. PubMed ID: 6430642 [Abstract] [Full Text] [Related]
13. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. Wilson ES, Cruickshank J, McMaster M, Weir RJ. Br J Obstet Gynaecol; 1984 Dec 14; 91(12):1254-60. PubMed ID: 6440589 [Abstract] [Full Text] [Related]
14. A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent. Yuzpe AA, Smith RP, Rademaker AW. Fertil Steril; 1982 Apr 14; 37(4):508-13. PubMed ID: 7040117 [Abstract] [Full Text] [Related]
15. Four years overall experience with a new low estrogen -- low progestogen oral contraceptive. Brat T. Acta Obstet Gynecol Scand Suppl; 1976 Apr 14; 54():67-70. PubMed ID: 788448 [Abstract] [Full Text] [Related]
16. A double-blind comparison of two oral contraceptives containing 50 mu g. and 30 mu g. ethinyl estradiol. Dionne P, Vickerson F. Curr Ther Res Clin Exp; 1974 Apr 14; 16(4):281-8. PubMed ID: 4208342 [Abstract] [Full Text] [Related]
17. [Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)]. Weijers MJ. Fortschr Med; 1982 Apr 29; 100(16):764-7. PubMed ID: 6211403 [Abstract] [Full Text] [Related]
18. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives. Hamerlynck JV, Vollebregt JA, Doornebos CM, Muntendam P. Contraception; 1987 Mar 29; 35(3):199-205. PubMed ID: 2956054 [Abstract] [Full Text] [Related]
19. Preliminary results from a swedish multicenter trial of a new low dose combined oral contraceptive. Ingemanson CA, Jägerhorn M, Zizala J, Nilsson B, Zador G. Acta Obstet Gynecol Scand Suppl; 1976 Mar 29; 54():71-5. PubMed ID: 788449 [Abstract] [Full Text] [Related]